Design and Synthesis of Novel Purine Analogues as Potential IL-1β Inhibitors Targeting Vascular Inflammation. [PDF]
Pournara DT +6 more
europepmc +1 more source
Separación y recuperación de fosfato y amonio de purines mediante sorción con zeolites sintéticas
Los purines de cerdo han sido tradicionalmente un problema medioambiental debido a su potencial para contaminar el suelo y las aguas cercanas. La gran concentración de granjas en zonas concretas y el hecho de que los purines no se puedan transportar a ...
Muiños Lázaro, Laura
core
Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu +10 more
wiley +1 more source
Enteric glia and purinergic signaling in health and disease. [PDF]
Gulbransen BD, Verkhratsky A, Parpura V.
europepmc +1 more source
Synthesis of New Push-Pull Purines from 9-Alkyl Substituted 2,6-Dichloropurines
Push-pull purine derivatives are attractive as sensors and reporters for biological applications. Recently the fluorescent purines as materials for electronic devices have also been developed.
Šišuļins, Andrejs +2 more
core
SLC1A3 promotes colorectal cancer progression by transporting extracellular aspartate into tumor cells, thereby activating the PKC/MDM2/p53 pathway to enhance proliferation. Reduced extracellular aspartate, combined with p53‐dependent suppression of CSF2 and IL17C, drives M2 macrophage polarization via immune modulation, macrophage recruitment, and M2 ...
Chao Deng +9 more
wiley +1 more source
PMO's protective wrap: Unraveling its surfactant-mediated stabilization for next-generation antisense therapies. [PDF]
Sharma SN, Gupta A, Sinha S.
europepmc +1 more source
MTAP Deficiency as a Metabolic Vulnerability in Cancer: Implications for Synthetic Lethal Therapy
MTAP deletion creates a therapeutically actionable metabolic vulnerability through MTA accumulation and PRMT5 dependency. This review summarizes the biochemical basis of MTAP‐directed synthetic lethality, emerging PRMT5/MAT2A inhibitors, clinicogenomic features of MTAP‐deleted tumors, and future strategies for precision oncology.
Hiroaki Ikushima, Hidenori Kage
wiley +1 more source
Cooperativity in E. coli aspartate transcarbamoylase is tuned by allosteric breathing. [PDF]
Miller RC +4 more
europepmc +1 more source
Disruption of purine <i>de novo</i> synthesis pathway impairs membrane homeostasis, intracellular survival, and virulence of <i>Brucella melitensis</i>. [PDF]
Yang G +10 more
europepmc +1 more source

